Trials / Recruiting
RecruitingNCT03233087
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
Detailed description
The study aims to investigate the role of candidate biomarkers in the diagnosis and prognosis of AA and AD. In the diagnosis part, we begin with a discovery phase where individually matched case-control study. Patients within each disease outcomes (i.e. AD, AMI, PE, AA without AD and healthy controls) are age and sex matched and retrospectively included.In the prognosis part of the study, patients with confirmed AA and AD are enrolled. The primary outcome is the all-cause mortality based on the death certificates. The secondary outcome is the in-hospital mortality according to the patients'medical records.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2017-07-28
- Last updated
- 2024-06-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03233087. Inclusion in this directory is not an endorsement.